Document is current
Any future updates will be listed below
-
Authors
Liang, Yao
Maeda, Osamu https://orcid.org/0000-0003-4700-6541
Miyata, Kazushi
Kanda, Mitsuro
Sugita, Shizuki
Shimizu, Dai
Nishida, Kazuki
Kodera, Yasuhiro
Ando, Yuichi
- License Information
-
More Information
Article History
Received: 25 May 2023
Accepted: 14 October 2023
First Online: 28 October 2023
Declarations
:
: Yasuhiro Kodera reports personal fees from Ono Pharmaceutical Co., Ltd. and Daiichi Sankyo Co., Ltd. and research funds from Chugai Pharmaceutical Co., Ltd., Tiho Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd. Yuichi Ando reports grants and personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Bayer Holding Ltd., research funds from Beigene, and grants from Geo Holdings outside the submitted work. The other authors have no conflicts of interest to declare.
: This study was conducted in accordance with the Ethical Guidelines for Medical and Biological Research Involving Human Subjects (Ministry of Health, Labor and Welfare, Japan) and the Declaration of Helsinki. This study was approved by the Institutional Review Board (approval no. 2021-0091). All patients provided written informed consent.
